is frontline io therapy appropriate in gastric cancer?
Published 4 years ago • 106 plays • Length 7:26Download video MP4
Download video MP3
Similar videos
-
4:12
metastatic gastric cancer: factors in selecting frontline therapy
-
4:15
global use of frontline therapy in metastatic gastric cancer
-
1:39
frontline i-o strategies in sclc: practical implications
-
3:03
gastric cancer: frontline checkpoint inhibitor trials
-
5:40
advanced/metastatic gastric cancer: beyond frontline
-
1:41
frontline approach in gastric cancer: double vs triplet
-
4:50
metastatic gastric cancer: promising frontline trials
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
10:43
chemo i-o in frontline mnsclc: pd-l1 tps 1%-49%
-
5:14
sequencing considerations in muc after frontline io
-
8:04
perioperative strategies in metastatic gastric cancer
-
10:16
ongoing research in gastric cancer; antiangiogenic therapy upfront and immunotherapy
-
10:03
guidelines for metastatic frontline therapy in gec
-
1:42
i-o in gastric/gej cancer
-
5:54
gastric cancer: global perspectives on maintenance therapy
-
7:02
later lines of therapy in metastatic gastric cancer
-
2:01
dr. fuchs on targeting angiogenesis in gastric cancer
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
5:30
chemo i-o in frontline mnsclc: pd-l1 tps greater than 50%